Bruce C. Cozadd received $15.5M in total compensation as Chairperson and CEO of Jazz Pharmaceuticals plc in FY2024. The largest component was $12.8M in stock awards. Source: SEC DEF 14A.
Executive Compensation Summary for Jazz Pharmaceuticals plc
Bruce C. Cozadd Salary and Compensation - Jazz Pharmaceuticals plc CEO Pay 2024
In fiscal year 2024, Bruce C. Cozadd, Chairperson and CEO of Jazz Pharmaceuticals plc (JAZZ), received total compensation of $15.5 million.
Bruce C. Cozadd's compensation breakdown includes: base salary of $1.2 million, stock awards valued at $12.8 million, non-equity incentive compensation of $1.5 million, and other compensation of $32K.
Jazz Pharmaceuticals plc (JAZZ) Executive Pay 2024
Jazz Pharmaceuticals plc's top 6 named executive officers received combined total compensation of $39.0 million in fiscal year 2024.
The named executive officers disclosed in Jazz Pharmaceuticals plc's 2024 proxy statement are:Bruce C. Cozadd (Chairperson and CEO) with total compensation of $15.5 million, Renée Galá (President and COO) with total compensation of $6.6 million, Robert Iannone (M.D., M.S.C.EExecutive Vice President,Global Head of R&D) with total compensation of $5.7 million, Philip L. Johnson (Executive Vice President and CFO) with total compensation of $5.2 million, Samantha Pearce (Executive Vice President CCO) with total compensation of $4.5 million, and Patricia Carr (Senior Vice President and CAO (Former Interim Principal Financial Officer)) with total compensation of $1.5 million.